Appropriate dosing of tirzepatide and metformin combination therapy requires individualized titration based on tolerability, therapeutic response, and patient-specific factors
Injections may be recommended for individuals who have difficulty maintaining healthy B12 levels through diet or oral supplements
Standing desks, walking meetings, and choosing stairs over elevators add movement without requiring dedicated exercise sessions
Wegovy is the first weight-loss drug to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, John Sharretts, director of the Division of Diabetes, Lipid Disorders and Obesity in the FDAs Center for Drug Evaluation and Research, said in a statement
Its clinical evidence for weight loss demonstrates superior efficacy compared to GLP-1R mono-agonists, a difference rooted not merely in additive peripheral effects but in central neural synergy